Intended for licensed healthcare professionals located in Switzerland.
Reporting suspected adverse reactions after authorisation of the medicinal product is of great importance. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are required to report any suspected new or serious side effects. See the “Undesirable effects” section of the Swiss Professional Information for the terms and conditions for reporting side effects.